Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Resources » Webinars » Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies
June 01, 2020
Sponsored by
LGC SeraCare Life Sciences

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

GenomeWebinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing.

This case-based discussion will provide an overview of best practices and lost opportunities, along with examples of the impact of current reporting practices on clinicians, patients, and their families.

Sponsored by

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

What's Popular?

In Genomics: Clinical Implementation

  1. Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

  2. Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021

    Premium

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.